Literature DB >> 7876606

Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies.

L G Salvadori1, M S Blake, M McCarty, J Y Tai, J B Zabriskie.   

Abstract

Antibodies reactive with group A streptococci (GAS) carbohydrate were studied by ELISA and in an indirect bactericidal assay. The ELISA used GAS carbohydrate covalently bound to phosphatidylethanolamine incorporated into liposomes so that both precipitating and nonprecipitating antibodies were measured. Sera from children from different geographic areas exhibited marked differences in levels of anti-GAS carbohydrate antibody, which increased with age. The antibodies were predominantly of IgG. In bactericidal assays, most of these sera promoted phagocytosis of several type-specific M-positive strains. Opsonization was also related to serum levels of anti-GAS carbohydrate antibodies. These opsonizing antibodies were depleted from the serum by absorption of the sera on an N-acetyl-D-glucosamine affinity column. Antibody eluted from this column could partially restore opsonization of GAS. Anti-GAS carbohydrate antibodies play a major role in these opsonophagocytosis assays.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876606     DOI: 10.1093/infdis/171.3.593

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Immunogenic and Genetic Factors in Rheumatic Fever.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer.

Authors:  Sascha A Kristian; John H Hwang; Bradley Hall; Emma Leire; John Iacomini; Robert Old; Uri Galili; Charles Roberts; Kary B Mullis; Mike Westby; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2015-05-05       Impact factor: 4.599

4.  Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera.

Authors:  Francis Michon; Samuel L Moore; John Kim; Milan S Blake; France-Isabelle Auzanneau; Blair D Johnston; Margaret A Johnson; B Mario Pinto
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 5.  Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.

Authors:  Preeyam Patel; John F Kearney
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

Review 6.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

7.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 8.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

9.  Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

Authors:  Harry S Courtney; David L Hasty; James B Dale
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 10.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.